key: cord-0909568-yjcqqfrw
authors: Maneira, Carla; Bermejo, Pamela Magalí; Pereira, Gonçalo Amarante Guimarães; de Mello, Fellipe da Silveira Bezerra
title: Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study
date: 2021-01-19
journal: FEMS Yeast Res
DOI: 10.1093/femsyr/foab004
sha: 802873478c760eb86ab4176cefe5379d8df437f1
doc_id: 909568
cord_uid: yjcqqfrw

Viral infections pose intense burdens to healthcare systems and global economies. The correct diagnosis of viral diseases represents a crucial step towards effective treatments and control. Biosensors have been successfully implemented as accessible and accurate detection tests for some of the most important viruses. While most biosensors are based on physical or chemical interactions of cell-free components, the complexity of living microorganisms holds a poorly explored potential for viral detection in the face of the advances of synthetic biology. Indeed, cell-based biosensors have been praised for their versatility and economic attractiveness, however, yeast platforms for viral disease diagnostics are still limited to indirect antibody recognition. Here we propose a novel strategy for viral detection in Saccharomyces cerevisiae, which combines the transductive properties of G Protein-Coupled Receptors (GPCRs) with the Yeast Surface Display (YSD) of specific enzymes enrolled in the viral recognition process. The GPCR/YSD complex might allow for active virus detection through a modulated signal activated by a GPCR agonist, whose concentration correlates to the viral titer. Additionally, we explore this methodology in a case study for the detection of highly pathogenic coronaviruses that share the same cell receptor upon infection (i.e. the Angiotensin-Converting Enzyme 2, ACE2), as a conceptual example of the potential of the GPCR/YSD strategy for the diagnosis of COVID-19.

might allow for active virus detection through a modulated signal activated by a GPCR agonist, whose concentration correlates to the viral titer. Additionally, we explore this methodology in a case study for the detection of highly pathogenic coronaviruses that share the same cell receptor upon infection (i.e., the Angiotensin-Converting Enzyme 2, ACE2), as a conceptual example of the potential of the GPCR/YSD strategy for the diagnosis of COVID-19.

Biosensors are analytical devices that employ a biological recognition element (e.g., enzymes, antibodies, DNA/RNA, whole cells, etc.) and respond to a target compound by generating a detectable signal that is typically proportional to the concentration of the analyte. Since the development of the first biosensor for glucose detection in the 1960s, biosensors have been extensively studied in multiple areas of research, attaining commercial success in clinical, food, environmental, and biothreat analysis (Bahadır and Sezgintürk 2015) .

In this context, developing biosensors for detecting viruses is particularly significant since the diagnosis of viral diseases is notably challenging. As viral infections often lead to generic symptoms, detection relies on time-consuming, expensive, or highly complex processes (Kievits et al. 1991) . Coronavirus 2 (SARS-CoV-2), responsible for the Coronavirus Disease 2019 . Current biosensing approaches and opportunities for COVID-19 testing have been deeply reviewed elsewhere (Bhalla et al. 2020; Chauhan et al. 2020; Cui and Zhou 2020; Fani et al. 2020 ; Morales-Narváez and Dincer 2020; Torabi et al. 2020 ).

Over the last two decades, enormous advances in nanotechnology, materials science, and genetic engineering tools have turned microbial biosensors into an increasingly hot topic in many areas of research, from environmental monitoring and food control to medical and biotechnological applications (Chang et al. 2017) . Among the advantages of using microbes as biosensors are their low cost and ease of production, including the possibility of applying genetic and/or evolutionary engineering techniques to improve selectivity and sensitivity towards target compounds (Ault and Broach 2006; Fukuda et al. 2011) . Additionally, unlike other detection technologies, microbial biosensors open up the possibility of highthroughput screening, enabling testing of multiple cell designs, thereby assisting synthetic biology applications.

The use of yeast in biosensors design offers powerful alternatives, given the ease of their genetic manipulation, high tolerance towards harsh conditions, eukaryotic nature, and the possibility of storage for long periods of time. Particularly, Saccharomyces cerevisiae is the most common chassis of choice due to the wealth of information as a model organism, numerous genome-editing tools, and its Generally Recognized As Safe (GRAS) status. In addition, S. cerevisiae has been exploited in virus research not only as a model system for understanding basic biological processes triggered by viruses, but also as a screening tool for antiviral drugs, as a production system for recombinant viral antigen, and as a vaccine vehicle (Galao et al. 2007 ). within the intracellular space, whereas in the latter, sensing happens through membrane-bound receptors. In addition to GPCRs, another useful extracellular system for biosensing applications is the Yeast Surface Display (YSD) of reporter proteins or enzymes on cell membranes, the expression of which can also be controlled in response to the target compound (Park 2020) . Although less explored in synthetic biology, examples of transcription-independent endeavors for yeast biosensing can be found elsewhere (Adeniran, Sherer and Tyo 2015) . While these strategies were proven efficient for numerous applications, the complexity of active virus detection remains a challenge for yeast-based viral diagnostics so far. Table 1 , which congregates some of the most prominent cell-based biosensors for the detection of human-pathogenic viruses, accounts for only one yeast biosensing strategy that targets an antibody response.

In this work, we explore how the integration of both the GPCR and YSDbased endeavors into a single yeast cell could represent a novel strategy for broadening the yeast biosensing opportunities for whole virus detection.

Subsequently, we assess how this strategy could potentially be effective for the diagnosis of challenging viral diseases with the design of a conceptual biosensor for SARS-CoV-2 detection that we have named 'CORONAYEAST'. To the best of our knowledge this is the first known attempt in using yeast as a whole-virus biosensing platform.

triggering a cellular response (Pierce, Premont and Lefkowitz 2002) . This activation is mediated by GPCRs in association with heterotrimeric guanine nucleotide-binding proteins (G proteins) -peripheral proteins composed of Gα, Gβ, and Gγ subunitshighly conserved among eukaryotes (Versele, Lemaire and Thevelein 2001) .

The GPCR systems identified in yeast are involved in glucose and pheromone sensing (Versele, Lemaire and Thevelein 2001) , the latter being the most relevant for biosensor design. Glucose sensing and signaling in S. cerevisiae is mediated by the GPCR/G protein pair Gpr1/Gpa2 (Gα), with no Gβ and Gγ proteins associated (Gancedo 2008 (Nakamura, Kondo and Ishii 2018) . Nevertheless, to guarantee functional coupling of heterologous GPCRs to yeast signaling, some additional engineering is required, as extensively reviewed by Lengger and Jensen (2020) . Recently, a model yeast cell for tuning GPCR signaling was constructed harboring a minimal set of signaling components (Shaw et al. 2019) .

Biosensor strategies targeting GPCR systems are of special interest for medical/health research, including pathogen detection and drug discovery (Doijen et al. 2019; Lengger and Jensen 2020) . Indeed, the role of mating GPCRs on fungal virulence in mammalian and plant hosts (Brown et al. 2018 ) was harnessed by

Ostrov and colleagues to detect pathogenic fungi (2017). In this remarkable work, the authors established a highly specific and sensitive S. cerevisiae-based biosensor for the detection of pathogen-derived peptides (fungal pheromones) in complex samples coupled to a readout visible to the naked eye.

In a similar manner, many viruses exploit human GPCR systems to their own benefit, taking control over the downstream signaling pathway to ultimately ensure their successful propagation (Sodhi, Montaner and Gutkind 2004) . A typical example is the chemokine receptor CCR5 -the primary co-receptor of HIV -which is crucial for viral entry and pathogenesis (Berger, Murphy and Farber 1999) . Not surprisingly, viruses have also evolved to encode their own GPCRs in order to evade the host's immune response and assist virus dissemination (Sodhi, Montaner and Gutkind 2004) .

Despite the role of GPCRs in viral pathogenesis, GPCR-based biosensors have been neglected for viral detection, which might be due to an insufficient understanding of the virus-receptor-ligand relationship or of the signaling pathway that is induced. Furthermore, the dependence on GPCRs (either cellular or viral) to gain entry to cells is currently limited to a group of viruses, while many others employ strategies independent of intracellular signaling (Grove and Marsh 2011) .

Besides GPCR-based biosensing techniques, surface display of peptides or proteins has allowed a plethora of applications in yeast in the last decade. Regarding the use of such strategy for the sensing of extracellular stimuli, S. cerevisiae has presented advantages in comparison to bacterial platforms because of its larger cell size that allows practical microscopic observations or cell sorting for quantitative measurements using flow cytometry (Shibasaki 2019) . Also, the post-translational modification machinery of yeasts grants the correct folding and secretion of glycosylated proteins that harbor multiple disulfide bonds, which makes YSD an interesting alternative for the expression of complex eukaryotic proteins (Han et al. 2018 ). These properties have endowed S. cerevisiae with biosensing abilities using cell surface engineering.

Overall, most yeast display systems consist of an expression cassette with a strong promoter controlling the coding region of a signal peptide fused to an anchor protein and the protein that should be displayed on the cell membrane surface.

Generally, this strategy uses structures known as glycosylphosphatidylinositols (GPIs) -normally covalently linked to the C-terminus of proteins -which provide stable bonds between these proteins and the cell membrane. Yeasts offer multiple options as cell surface anchor proteins, including Aga1p, Aga2p, Cwp1p, Cwp2p, Tip1p, Flo1p, Sed1p, YCR89w, and Tir1p (Cherf and Cochran 2015) . Usually, the coding sequence of an epitope is also introduced in the expression cassette to allow the exposure of the displayed protein in immunological assays (Yang et al. 2019) .

The fusion of the protein of interest to the GPI-anchor protein generally results in the exposure of up to 100,000 copies of the fused protein to the cell surface of S.

cerevisiae (Boder and Wittrup 2000) .

Traditionally, YSD technology has enabled the development of biosensors through a signal-transducing element activated by a promoter region of a gene that responds to environmental changes (Shibasaki 2019) . This approach allowed the successful application of S. cerevisiae as a glucose cell sensor, where the expression of a fluorescent protein-encoding gene inserted between a secretory signal sequence and the α-agglutinin-encoding gene was induced by the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter (for glucose-rich

conditions) or by the Candida tropicalis isocitrate lyase (UPR-ICL) promoter (for glucose depletion conditions) (Ye et al. 2000) . A similar strategy has already been proposed for sensing ammonium and phosphate ions .

Although important advances have been made using the signal transduction methodology, it represents a narrow possibility regarding biosensing activityespecially with respect to virus recognition. Extracellular modifications caused by viral infections are complex and hardly capable of being naturally sensed by yeasts to promote cell surface signaling. It is important to note that a virus receptor is not necessarily a protein that interacts with some ligand for signaling purposes or cell- The YSD strategy expands its applicability when dealing with protein-protein interactions, hence posing as a promising alternative for using yeasts as viral detection biosensors. The display of the ZZ domain derived from Staphylococcus aureus on S. cerevisiae cell surface has been used to adsorb IgG type antibodies and used as an immunoadsorbent for Enzyme-Linked ImmunoSorbent Assay (ELISA) of antibodies or for sandwich ELISA of antigens (e.g. human serum albumin) (Nakamura et al. 2001) . Yeast cells expressing both single-chain variable fragment (scFv) antibodies and gold-binding peptide (GBP) on its cell surface have been successfully employed to detect Salmonella TM43-E10 surface antigen through sandwich format (Venkatesh et al. 2015) . More recently, a modified yeast was described to display Hepatitis C Virus (HCV) core antigen linked to GBP as a dualaffinity biobrick chimera, able to detect anti-HCV core antibody as an optical or 

Advances in using S. cerevisiae as a genetically renewable whole-cell immunoadsorbent could lead to exciting applications for POC immunoassay diagnostics. However, when dealing with newly discovered diseases, the utilization of antibodies or antigens for diagnostic purposes possesses an important drawback, since extensive knowledge on immunological patterns is required for these applications. When confronted with a pandemic situation, such as the COVID-19

outbreak, whole-virus detection represents a more effective and sensitive tool for disease control. Even so, no yeast-based strategy has yet been described. Next, we assess how a combination of the GPCR and the YSD-based strategies could represent an innovative alternative to harness S. cerevisiae as a virus biosensing module.

It is well known that virus infections are mediated by their binding to specific surface molecules on target cells, in a highly specific manner. These receptors are usually proteins required by the cell for some normal function and are co-opted by the virus during its entry (Coffin 2013). Given the viral infection mechanism and yeast's biosensing capabilities, a sole GPCR or YSD strategy falls short in detecting the complex and specific changes of this pathogenicity scenario.

Therefore, here we contemplate how the combination of both above-disclosed strategies in a GPCR/YSD complex could broaden the possibilities of using S.

cerevisiae as a detection platform for whole viruses. By harnessing the signaling sensitivity and specificity of GPCRs with the multiple options of cell surface immobilization, virus detection by engineered yeast cells could be indirectly determined through the sensing of metabolite imbalances caused by the dual activity of a displayed protein -that could act as a viral receptor or as a catalytic enzyme. In other words, an immobilized protein that has a natural catalytic activity and also enrolls in viral binding might have its function altered in the presence of the virus, leading to environmental changes that might be transduced by a GPCR system. A graphic scheme of this strategy is presented in Figure 1 .

The GPCR/YSD strategy showcases the possibility of magnifying the range of GPCR-based biosensors for pathogen detection, thereby enabling the use of rapid S. cerevisiae-based detection tests, similar to the one described by Ostrov et al. (2017) , for the recognition of pathogens that do not necessarily bear a GPCR system. This is the case for important prokaryotic pathogens (bacteria, archaea, and protozoa) and most viruses, which together account for most of the agents responsible for infectious diseases worldwide (Wolfe, Dunavan and Diamond 2007; Jones et al. 2008) .

Interestingly, such a GPCR/YSD complex strategy finds a parallel in the traditional concept of a biosensor in which two modules, known as the bioreceptor and the transducer, are employed for functional sensing. Even though the yeast cell performs as both the receiving and transducing elements -as is the case for all cellbased biosensors -it is indisputable that within the cell such modules can be identified. In this correlation, the yeast display of viral-interacting proteins functions in a similar fashion as a receptor module -directly interacting with the virus, while the GPCR acts as the transducer, ultimately leading to the prompt of the output protein through the sensing of a by-product.

In the next section, we envision how such a strategy could be employed for the detection of SARS-CoV-2 and, potentially, other viruses that use the same cell receptor upon infection. The conceptual example, named CORONAYEAST, was based on the recent findings on the host-virus interaction patterns of the highly impacting pandemic pathogen responsible for the COVID-19 outbreak, serving as a theoretical baseline that might be exported for other viral infections. The development of this concept could lead to actual physical diagnostics devices when exposed to the well-known design-build-test-learn cycle.

6. CORONAYEAST: an S. cerevisiae-based diagnostic concept for COVID-19

By January, 2021, SARS-CoV-2 has infected more than 90 million people and caused nearly 2 million deaths worldwide, posing a threat not only to healthcare systems but also to the global economy. Confronted with this scenario, we showcase how we could benefit from the GPCR/YSD strategy for the development of a COVID-

19 diagnosis platform, based on an S. cerevisiae biosensor that here we call CORONAYEAST. This biosensor concept is built upon the GPCR/YSD strategy for enabling the sensing of a target that is not naturally sensed by conventional -GPCRonly or YSD-only -concepts: in this case, a whole virus. It stands out as a potential application example of how the GPCR/YSD strategy could be decisive for the development of biosensors for highly-important economic and social purposes.

In summary, the biosensor functioning is based upon the dual role played by the Angiotensin-Converting Enzyme 2 (ACE2) in human cells. It is the SARS-CoV-2 sole receptor (Li et al. 2003) as well as the effector of Angiotensin II (Ang II) homeostasis within the Renin-Angiotensin System (RAS) (Burrell et al. 2004 ). In this system, Ang II acts as the agonist of the human Ang II GPCR type 1 (AT 1 ) (Zhang et al. 2017) , which triggers a cell response through the activation of a signaling cascade. The heterologous expression of ACE2 and AT 1 in the yeast strain would allow the mimicking of the human RAS via the GPCR/YSD strategy. Coupled with the downstream insertion of easy-to-observe and -interpret reporter genes, this strain could represent a promising alternative for viral detection.

The following sections cover in more depth (1) the motivation behind this concept, (2) the mechanism behind SARS-CoV-2 infection, and the RAS imbalance that allowed for its development, and (3) Seo et al. 2020) . Even so, microorganism-based approaches for SARS-CoV-2 sensing, such as yeast-based biosensors, are still an unexplored field that could offer high sensitivity, low cost, and equipment independence.

In this context, the full understanding of the physiological outcomes of the SARS-CoV-2 infection, more specifically, its effects over the Ang II levels allow us to contemplate the application of the GPCR/YSD concept for the development of such a system. Following, we will cover this issue as an important foundation for the development of CORONAYEAST. (Ang 1-7).

Ang II acts as a potent vasoconstrictor and pro-inflammatory particle (Donoghue et al. 2000) through the sensing and activation of the AT 1 receptor (Chiu et al. 1991; Zhang et al. 2017) . Ang 1-7 counteracts Ang II effects (Ferrario et al. 1997 (Ferrario et al. , 1998 On top of its physiological outcomes, the exacerbation of the CTD-ACE2-Ang II-AT 1 axis due to the viral infection stands out not only as a potential therapy target but also as a pivot for the development of novel COVID-19 diagnostics tests, such as CORONAYEAST, which recognizes and marks the viral presence through Ang II sensing.

How could the GPCR/YSD principle be implemented for the COVID-19 diagnosis?

As previously presented, the development of the yeast biosensor concept emerges from understanding the two different roles of ACE2 in the human organism:

(1) as an essential component of the RAS, mediating Ang II degradation into Ang 1-7 (Tikellis and Thomas 2012) ; and (2) as a viral receptor (Hoffmann et al. 2020) , in an infection scenario. The decreased Ang II concentration would consequently limit the activation of the AT 1 receptor and the subsequent promoter.

Therefore On the other hand, the challenge of engineering a recombinant yeast strain that expresses the AT 1 receptor was already described by Nakamura, Ishii and Kondo (2014) . The authors succeeded in the functional activation of the human GPCR signal by inserting a single mutation of Ala at Asn295 into the AGTR1 receptor and by using the chimeric Gα protein, G i3 tp. The signal transduction activated by the AGTR1(N295A)/G i3 tp complex in the presence of Ang II, modulates the FIG1 promoter, which, fused to the reporter protein ZsGreen, emits fluorescence once activated.

As for the Ang II delivery to the system, a full comprehension via empirical analysis of the interaction dynamics between the SARS-CoV-2 Spike protein and the yeast-displayed ACE2 deems necessary. Uncovering the timing underlying the blockage of the ACE's catalytic function is imperative for understanding when and how Ang II should be delivered to the system. In this matter, Ishii et al. (2012) have described a plasmid enabling Ang II secretion which allows autocrine signaling and could be used in the formation of an autonomous biosensing device. However, if considered pertinent, the addition of Ang II to the system as a running buffer is not only feasible but also practical.

As described by Nakamura, Ishii and Kondo (2014) , the fluorescent signal emitted by ZsGreen can be effectively modulated by the concentration of Ang II via the AT 1 -based transduction. Levels as low as 368 μM of Ang II have been detected by the heterologous AT 1 , hence posing as a highly sensitive biosensor. It is postulated that the fluorescence emitted by the biosensing strain would be proportional to the viral titer: the greater the presence of SARS-CoV-2, the greater the ACE2 downregulation and, therefore, the greater the concentration of extracellular Ang II. The opposite should also be true and the time for sensing differential Ang II concentration should be around 4 hours, as previously stated by the group. This strain could potentially be used in laboratory tests as the biosensing component of a quantitative diagnostic, as shown in Figure 4A .

In order to establish a multi-mode device that would not rely solely on laboratory apparatus for results interpretation, the pheromone signaling cascade could be coupled to a biosynthetic pathway that ultimately produces a pigment visible to the naked eye when activated. The use of lycopene for this matter has

already been described as highly sensitive and specific (Ostrov et al. 2017) . In a similar fashion, yeast-based GPCR/YSD biosensing devices such as the CORONAYEAST could be coupled to the lycopene production pathway enabling the qualitative detection of SARS-CoV-2 without the need for additional equipment. The simple addition of the yeast-based biosensor to clinical samples would allow a naked-eye visible color change, which should occur after 8 hours of incubation (Ostrov et al. 2017 ). An illustrative representation of this qualitative device is shown in Figure 4B .

Briefly, the biosensing strain in ready-to-test and control conditions could be packed in a paper container, as described by Ostrov et al. (2017) . A prominent cellulose dipstick would be immersed in the sample and, by capillarity, the specimen would come in contact with the biosensory yeasts, activating or not the reporter gene due to the presence or absence of viral particles, respectively. As it is known that saliva is a large reservoir of SARS-CoV-2 (Azzi et al. 2020) , the development of a non-invasive test would allow the testing to be personal and confidential. The dissemination of this type of POC test -simple, sensitive, specific, and inexpensivewould allow for effective tracking of the mobility dynamics of viruses. In a hypothetical scenario, users could share their test results through a mobile application at regular intervals. These data could be accessed by appropriate health organizations, allowing the application of effective public policies to control the spread of the disease.

The main advantages of the CORONAYEAST diagnostic compared to current testing techniques would be: (1) To be functional throughout the infection manifestation, once it is responsive to active viral particles capable of binding with ACE2;

(2) To be highly specific to ACE2-binding viruses, since it is based on a GPCR signaling pathway that is only activated through the presence of Ang II; (3) To be highly sensitive, because small changes in Ang II concentration can be detected by the AT 1 receptor, leading to significant changes in the reporter genes expression intensity (Nakamura, Ishii and Kondo 2014) ; (4) To be inexpensive, by reliance on solely yeast propagation (when expressing an Ang II autocrine signaling), with no resistance markers that must be maintained; (5) Remarkably, the CORONAYEAST concept detailed here should be able to detect all viruses dependent on ACE2 to initiate infection: SARS-CoV-2, SARS-CoV, and HCoV-NL63. While high ACE2-affinity has been thoroughly described for SARS-CoV in a similar fashion as for SARS-CoV-2, the interaction with HCoV-NL63 is weaker, which is proposed to partly explain the different pathological consequences of infection by HCoV-NL63 when compared to the other two viruses (Mathewson et al. 2008; Abdul-Rasool and Fielding 2010) . Empirical clinical assays with HCoV-NL63 and the biosensing strain deems necessary to infer whether the interaction between HCoV-NL63 and the CORONAYEAST would be strong enough to lead to detection. In addition, it is important to notice that other human pathogenic coronaviruses -such as HCoV-229E and HCoV-OC43, responsible for common cold, do not use ACE2 for binding to the host cell and, therefore, would not be detected by the CORONAYEAST.

Given the similarities between ACE2-dependent viruses' structural components and infection mechanisms, the CORONAYEAST could stand out as a practical multi-diagnostic alternative. That versatility could introduce cross-reactions among ACE2-binding coronaviruses, but since the surveillance of highly-impacting SARS-like pathogens has not yet overlapped (Peeri et al. 2020) , it would not be an issue. Furthermore, it might also play an important role in the detection of new human-pathogenic coronavirus strains that may develop over time, as the ACE2 protein is critical for the infection of most of the coronaviruses that have been responsible for pandemics, and mutation rates of the viral genome are very high (Pachetti et al. 2020; Tang et al. 2020a) .

As To substantiate the universality of this approach and provide another application example, an envisioned execution is the detection of the Human T cell Leukemia virus (HTLV), which is associated with leukemia and neurological syndromes. It has been described that HTLV's receptor-binding domain interacts with GLUT-1 -the mammalian glucose transporter -, inhibiting the sugar transport and finally perturbing the glucose metabolism (Manel et al. 2003) . The expression of GLUT-1 in a "null" hexose transport S. cerevisiae background has already been described by Wieczorke et al. (2003) . We envision that the GPCR/YSD strategy could enable HTLV's sensing through extracellular glucose concentration variation due to the virus interaction with GLUT-1 (acting as the membrane receptor) followed by GPCR-mediated glucose detection coupled, for instance, to the mating pathway. would be the use of anchored α-amylases in yeast, as previously described by Selwal et. al. (2017) , for the construction of a novel S. cerevisiae starch biosensor.

Again, the amylase would act as the receptor (using the YSD strategy), while signal transduction could be performed by a glucose-inducible promoter or a GPCR system -knowing that this sugar is the product of the enzymatic activity over starch. Starch concentration would be correlated to the hexose presence in the medium, requiring previous standardization protocols for the use as a functional biosensor.

The prospect of expanding the promising, yet underexplored, field of yeastbased viral biosensors via the implementation of the GPCR/YSD strategy presented here might lead to important advances in detection devices in several fields.

Ultimately, we hope this review serves as a catalyst for new ideas in the yeastbiosensors research field, addressing current and future detection challenges.

We would like to thank Dr. We also thank Dr. Eleanor E. Campbell for providing linguistic improvements. scFv: single-chain variable fragment.

Understanding Human Coronavirus HCoV-NL63

Yeast-based biosensors: design and applications

Detection of hepatitis C core antibody by dual-affinity yeast chimera and smartphone-based electrochemical sensing

Creation of GPCR-based chemical sensors by directed evolution in yeast

Saliva is a reliable tool to detect SARS-CoV-2

Yeast expression systems: overview and recent advances

Applications of commercial biosensors in clinical, food, environmental, and biothreat/biowarfare analyses

Presumed asymptomatic carrier transmission of COVID-19

Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung

A walk-through of the yeast mating pheromone response pathway

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

Opportunities and challenges for biosensors and nanoscale analytical tools for pandemics: COVID-19

Yeast surface display for directed evolution of protein expression, affinity, and stability

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors

CRISPR-Cas12-based detection of SARS-CoV-2

Fungal G-protein-coupled receptors: mediators of pathogenesis and targets for disease control

Yeast systems for the commercial production of heterologous proteins

ACE2, a new regulator of the reninangiotensin system

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

Biosensors for the detection of bacterial and viral clinical pathogens

A review on viral biosensors to detect human pathogens

Electrochemical biosensors for pathogen detection

Microbially derived biosensors for diagnosis, monitoring and epidemiology

Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2

Applications of yeast surface display for protein engineering

Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells

Diagnostic methods and potential portable biosensors for coronavirus disease 2019

Origin and evolution of pathogenic coronaviruses

Ultrasensitive and visual detection of SARS-CoV-2 using allin-one dual CRISPR-Cas12a assay

Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool

A novel angiotensin-converting enzymerelated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics

Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis

Molecular evolution of human coronavirus genomes

Amplification of agonist stimulation of human Gprotein-coupled receptor signaling in yeast

Saccharomyces cerevisiae: a versatile eukaryotic system in virology

The early steps of glucose signalling in yeast

SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2

Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63

The cell biology of receptor-mediated virus entry

Detection and quantification of label-free infectious adenovirus using a switch-on cell-based fluorescent biosensor

Point of care technologies for HIV

Redesigning of microbial cell surface and its application to whole-cell biocatalysis and biosensors

GPCR drug discovery: new agents, targets and indications

Direct and dynamic detection of HIV-1 in living cells

Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Development and evaluation of a rapid CRISPRbased diagnostic for COVID-19

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Cell wall trapping of autocrine peptides for human G-protein-coupled receptors on the yeast cell surface

Does SARS-CoV-2 has a longer incubation period than SARS and MERS

DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis

Global trends in emerging infectious diseases

Ultrasensitive detection of pathogenic viruses with electrochemical biosensor: State of the art

NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

Study on the mechanism of Bioelectric Recognition Assay: evidence for immobilized cell membrane interactions with viral fragments

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Electrochemical sensors and biosensors for influenza detection

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Engineering G protein-coupled receptor signalling in yeast for biotechnological and medical purposes

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Receptor recognition mechanisms of coronaviruses: a decade of structural studies

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Molecular immune pathogenesis and diagnosis of COVID-19

Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management

Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Antibody responses to SARS-CoV-2 in patients with COVID-19

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond

A novel reverse transcription loop-mediated isothermal amplification method for rapid detection of SARS-CoV-2

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections

The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV

Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2

Engineering cellular biosensors with customizable antiviral responses targeting hepatitis B virus engineering cellular biosensors with customizable antiviral responses targeting hepatitis B virus

Development of a portable, ultrarapid and ultra-sensitive cell-based biosensor for the direct detection of the SARS-COV-2 S1 spike protein antigen

Yeast surface display platform for rapid discovery of conformationally selective nanobodies

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Selective naked-eye detection of SARS-CoV-2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles

The impact of biosensing in a pandemic outbreak: COVID-19

Construction of a yeast-based signaling biosensor for human angiotensin II type 1 receptor via functional coupling between Asn295-mutated receptor and Gpa1/G i3 chimeric Gα

Biosensing techniques in yeast: G-protein signaling and protein-protein interaction assays for monitoring ligand stimulation and oligomer formation of heterologous GPCRs

Development of novel whole-cell immunoadsorbents by yeast surface display of the IgG-binding domain

Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)

A modular yeast biosensor for low-cost point-of-care pathogen detection

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Review-Chemical and biological sensors for viral detection

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Surface display technology for biosensor applications: a review

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Development of a novel, ultra-rapid biosensor for the qualitative detection of hepatitis B virus-associated antigens and anti-HBV, based on "membrane-engineered" fibroblast cells with virusspecific antibodies and antigens

Seven-transmembrane receptors

Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection

Biosensors for detecting viral and bacterial infections using host biomarkers: a review

Biosensors for the detection of respiratory viruses: a review

A B cell-based sensor for rapid identification of pathogens

Glucose-sensing and -signalling mechanisms in yeast

Angiotensin-(1-7): an update

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

An alternative medical diagnosis method: biosensors for virus detection

Functional display of amylase on yeast surface from Rhizopus oryzae as a novel enzyme delivery method

Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistorbased biosensor

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

Cell entry mechanisms of SARS-CoV-2

Structural basis of receptor recognition by SARS-CoV-2

Engineering a model cell for rational tuning of GPCR signaling

Bio-sensing using cell surface display: principles and variations of a cell sensor

Intelligent yeast strains with the ability to self-monitor the concentrations of intra-and extracellular phosphate or ammonium ion by emission of fluorescence from the cell surface

The preparation and function of the hypertensin-converting enzyme

Viral hijacking of G-protein-coupled-receptor signalling networks

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

On the origin and continuing evolution of SARS-CoV-2

Laboratory diagnosis of COVID-19: current issues and challenges

The trinity of COVID-19: immunity, inflammation and intervention

Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

Aptamers, the bivalent agents as probes and therapies for coronavirus infections: a systematic review

An improved yeast surface display platform for the screening of nanobody immune libraries

Diagnosing COVID-19: the disease and tools for detection

Antibody responses to SARS-CoV-2 short-lived

Yeast dual-affinity biobricks: progress towards renewable whole-cell biosensors

Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice

Sex and sugar in yeast: two distinct GPCR systems

Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison

SalivaDirect: simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

Detection of SARS-CoV-2 in different types of clinical specimens

Characterisation of mammalian GLUT glucose transporters in a heterologous yeast expression system

Origins of major human infectious diseases

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Crystal structure of NL63 respiratory coronavirus receptorbinding domain complexed with its human receptor

CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia

Evidence for gastrointestinal infection of SARS-CoV-2

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings

Development of novel surface display platforms for anchoring heterologous proteins in Saccharomyces cerevisiae

Construction of an engineered yeast with glucoseinducible emission of green fluorescence from the cell surface

Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform

Structural basis for selectivity and diversity in angiotensin II receptors

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target